MHC‐restricted Ag85B‐specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice. Issue 9 (19th June 2019)
- Record Type:
- Journal Article
- Title:
- MHC‐restricted Ag85B‐specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice. Issue 9 (19th June 2019)
- Main Title:
- MHC‐restricted Ag85B‐specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice
- Authors:
- Komine‐Aizawa, Shihoko
Jiang, Jiansheng
Mizuno, Satoru
Hayakawa, Satoshi
Matsuo, Kazuhiro
Boyd, Lisa F.
Margulies, David H.
Honda, Mitsuo - Abstract:
- Abstract: Despite efforts to develop effective treatments and vaccines, Mycobacterium tuberculosis ( Mtb ), particularly pulmonary Mtb, continues to provide major health challenges worldwide. To improve immunization against the persistent health challenge of Mtb infection, we have studied the CD8 + T cell response to Bacillus Calmette‐Guérin (BCG) and recombinant BCG (rBCG) in mice. Here, we generated CD8 + T cells with an rBCG‐based vaccine encoding the Ag85B protein of M. kansasii, termed rBCG‐Mkan85B, followed by boosting with plasmid DNA expressing the Ag85B gene (DNA‐Mkan85B). We identified two MHC‐I (H2‐K d )‐restricted epitopes that induce cross‐reactive responses to Mtb and other related mycobacteria in both BALB/c (H2 d ) and CB6F1 (H2 b/d ) mice. The H2‐K d ‐restricted peptide epitopes elicited polyfunctional CD8 + T cell responses that were also highly cross‐reactive with those of other proteins of the Ag85 complex. Tetramer staining indicated that the two H2‐K d ‐restricted epitopes elicit distinct CD8 + T cell populations, a result explained by the X‐ray structure of the two peptide/H2‐K d complexes. These results suggest that rBCG‐Mkan85B vector‐based immunization and DNA‐Mkan85B boost may enhance CD8 + T cell response to Mtb, and might help to overcome the limited effectiveness of the current BCG in eliciting tuberculosis immunity. Abstract : Ag85B specific polyfunctional CD8 + T cells are inducible by recombinant BCG encoding the Ag85B protein ofAbstract: Despite efforts to develop effective treatments and vaccines, Mycobacterium tuberculosis ( Mtb ), particularly pulmonary Mtb, continues to provide major health challenges worldwide. To improve immunization against the persistent health challenge of Mtb infection, we have studied the CD8 + T cell response to Bacillus Calmette‐Guérin (BCG) and recombinant BCG (rBCG) in mice. Here, we generated CD8 + T cells with an rBCG‐based vaccine encoding the Ag85B protein of M. kansasii, termed rBCG‐Mkan85B, followed by boosting with plasmid DNA expressing the Ag85B gene (DNA‐Mkan85B). We identified two MHC‐I (H2‐K d )‐restricted epitopes that induce cross‐reactive responses to Mtb and other related mycobacteria in both BALB/c (H2 d ) and CB6F1 (H2 b/d ) mice. The H2‐K d ‐restricted peptide epitopes elicited polyfunctional CD8 + T cell responses that were also highly cross‐reactive with those of other proteins of the Ag85 complex. Tetramer staining indicated that the two H2‐K d ‐restricted epitopes elicit distinct CD8 + T cell populations, a result explained by the X‐ray structure of the two peptide/H2‐K d complexes. These results suggest that rBCG‐Mkan85B vector‐based immunization and DNA‐Mkan85B boost may enhance CD8 + T cell response to Mtb, and might help to overcome the limited effectiveness of the current BCG in eliciting tuberculosis immunity. Abstract : Ag85B specific polyfunctional CD8 + T cells are inducible by recombinant BCG encoding the Ag85B protein of Mycobacterium kansasii (rBCG‐Mkan85B), followed by boosting with plasmid DNA expressing the Ag85B gene (DNA‐Mkan85B). We identified two MHC‐I (H2‐K d )‐restricted epitopes that induce cross‐reactive responses to M. tuberculosis and other mycobacteria. … (more)
- Is Part Of:
- European journal of immunology. Volume 49:Issue 9(2019)
- Journal:
- European journal of immunology
- Issue:
- Volume 49:Issue 9(2019)
- Issue Display:
- Volume 49, Issue 9 (2019)
- Year:
- 2019
- Volume:
- 49
- Issue:
- 9
- Issue Sort Value:
- 2019-0049-0009-0000
- Page Start:
- 1399
- Page End:
- 1414
- Publication Date:
- 2019-06-19
- Subjects:
- CD4+ T Cells -- CD8+ T Cells -- MHC‐I presentation -- Mycobacterium tuberculosis, recombinant BCG
Immunology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/eji.201847988 ↗
- Languages:
- English
- ISSNs:
- 0014-2980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.730100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17752.xml